General Information
BioAge BGE105-005
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Proof-of-Concept Study to Investigate Efficacy and Safety of Oral Azelaprag plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over.
| Protocol | BGE105-005 |
|---|---|
| Identifier | |
| UID | 95dfd949-be52-4cda-a524-4c50b8755a4b |
| Status | Pending Closeout |
| Phase | 2 |
| Category | / Adult |
| Launch Year | 2024 |
| NCT Number | - |
| Created | 2024-04-25 13:21 |
| Last Updated | 2025-05-27 21:49 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2024-11-20 | No |
| Enrollment Open | 2024-07-11 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2024-06-24 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2025-03-24 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | BioAge Labs, Inc |
|---|---|
| Division | BioAge Labs, Inc |
| Team | BioAge Labs, Inc |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | LightSkyBlue |
| Currency | - |
